Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.385EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.385ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.385EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.385EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.385ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.45EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.244EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.244ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.244EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.244EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.244ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.244ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.289EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.289ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.289ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.289EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.289EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.7.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.7.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used